Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is a publicly traded the market company. As of September 11, 2026, ELOX trades at $16.51 with a market cap of $56.94M and a P/E ratio of -0.98. ELOX moved +1.38% today. Year to date, ELOX is +1363540.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $23.40. Analyst consensus is strong buy with an average price target of $40.33. Rallies surfaces ELOX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ELOX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $16.51 |
| Market Cap | $56.94M |
| P/E Ratio | -0.98 |
| EPS | $-16.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.40 |
| 52-Week Low | $0.00 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-36.06M |
| Gross Margin | 0.00% |
3 analysts cover ELOX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.33.